NCT03357757 2025-06-26
LATENT
AHS Cancer Control Alberta
Phase 2 Completed
Clinical Trials
5 trialsNCT03440567 2025-03-26
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
City of Hope Medical Center
Phase 1 Completed
NCT03046953 2024-07-16
AVAIL-T
University of Birmingham
Phase 2 Completed
NCT03905135 2022-09-13
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03147404 2019-12-30
MS100070-0177
Samsung Medical Center
Phase 2 Completed